BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7570890)

  • 21. Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam.
    Thanh NV; Cowman AF; Hipgrave D; Kim TB; Phuc BQ; Cong LD; Biggs BA
    Trans R Soc Trop Med Hyg; 2001; 95(5):513-7. PubMed ID: 11706663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial.
    Priotto G; Kabakyenga J; Pinoges L; Ruiz A; Eriksson T; Coussement F; Ngambe T; Taylor WR; Perea W; Guthmann JP; Olliaro P; Legros D
    Trans R Soc Trop Med Hyg; 2003; 97(3):325-30. PubMed ID: 15228253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria.
    Oduola AM; Omitowoju GO; Sowunmi A; Makler MT; Falade CO; Kyle DE; Fehintola FA; Ogundahunsi OA; Piper RC; Schuster BG; Milhous WK
    Exp Parasitol; 1997 Nov; 87(3):283-9. PubMed ID: 9371095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia.
    Seboxa T; Mao P; Pinchouk N; Anbessie J; Alemu H; Diro E
    Ethiop Med J; 2010 Oct; 48(4):285-91. PubMed ID: 21280430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine combination in semi-immune children in Zaria, northern Nigeria.
    Lege-Oguntoye L; Adagu SI; Werblinska B; Ogala WN; Slotboom AB
    Trans R Soc Trop Med Hyg; 1990; 84(4):505-6. PubMed ID: 2091339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
    Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O
    Malar J; 2007 Jun; 6():80. PubMed ID: 17570848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
    J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug resistant tropical malaria in the Republic of Guinea (West Africa)].
    Popov AF; Popova NI; Chirkov VP; Kamara F
    Med Parazitol (Mosk); 2003; (2):41-3. PubMed ID: 12886592
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.
    von Seidlein L; Bojang K; Jones P; Jaffar S; Pinder M; Obaro S; Doherty T; Haywood M; Snounou G; Gemperli B; Gathmann I; Royce C; McAdam K; Greenwood B
    Am J Trop Med Hyg; 1998 May; 58(5):638-44. PubMed ID: 9598454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
    Rwagacondo CE; Niyitegeka F; Sarushi J; Karema C; Mugisha V; Dujardin JC; Van Overmeir C; van den Ende J; D'Alessandro U
    Am J Trop Med Hyg; 2003 Jun; 68(6):743-7. PubMed ID: 12887037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
    Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
    Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrimethamine versus artesunate plus sulfamethoxypyrazine/pyrimethamine.
    Rulisa S; Gatarayiha JP; Kabarisa T; Ndayisaba G
    Am J Trop Med Hyg; 2007 Oct; 77(4):612-6. PubMed ID: 17978058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
    Marquiño W; Ylquimiche L; Hermenegildo Y; Palacios AM; Falconí E; Cabezas C; Arróspide N; Gutierrez S; Ruebush TK
    Am J Trop Med Hyg; 2005 May; 72(5):568-72. PubMed ID: 15891131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
    Adam I; A-Elbasit IE; Idris SM; Malik EM; Elbashir MI
    Ann Trop Med Parasitol; 2005 Jul; 99(5):449-55. PubMed ID: 16004704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
    Thapa S; Hollander J; Linehan M; Cox-Singh J; Bista MB; Thakur GD; Davis WA; Davis TM
    Am J Trop Med Hyg; 2007 Sep; 77(3):423-30. PubMed ID: 17827354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.